Role of Vitamin D Deficiency in Systemic Inflammatory Markers Across Chronic Endocrine Diseases
DOI:
https://doi.org/10.71000/ppkpr715Keywords:
C-reactive protein, Endocrine System Diseases, Erythrocyte Sedimentation Rate, Hypothyroidism, , Neutrophil-to-Lymphocyte Ratio, , Polycystic Ovary Syndrome, Vitamin DAbstract
Background: Vitamin D is a fat-soluble secosteroid that plays an essential role in calcium homeostasis and skeletal health. Recent findings have also linked vitamin D to immune modulation and inflammatory regulation in endocrine dysfunctions. Chronic endocrine disorders such as Type 2 Diabetes Mellitus (T2DM), Polycystic Ovary Syndrome (PCOS), and hypothyroidism often exhibit persistent low-grade systemic inflammation, which may be exacerbated by vitamin D deficiency.
Objective: To assess the relationship between serum vitamin D levels and systemic inflammatory markers in patients diagnosed with T2DM, PCOS, and hypothyroidism.
Methods: A cross-sectional study was conducted at a tertiary healthcare center between January and June 2024, including 120 patients aged 25–50 years with a clinical diagnosis of T2DM, PCOS, or hypothyroidism. Participants were categorized into three groups based on serum 25-hydroxyvitamin D [25(OH)D] levels: deficient (<20 ng/mL), insufficient (20–30 ng/mL), and sufficient (>30 ng/mL). Inflammatory markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and neutrophil-to-lymphocyte ratio (NLR) were measured. Data were analyzed using one-way ANOVA for group comparisons and Pearson correlation to assess associations, with p-values <0.05 considered statistically significant.
Results: CRP (12.5 ± 5.4 vs. 5.6 ± 2.3 mg/L; p = 0.01), ESR (40.5 ± 17.6 vs. 27.6 ± 10.1 mm/h; p = 0.03), and NLR (4.1 ± 1.4 vs. 2.9 ± 1.0; p = 0.02) were significantly higher in vitamin D-deficient patients compared to those with sufficient levels. Strong negative correlations were noted between 25(OH)D and CRP (r = –0.46, p < 0.01), ESR (r = –0.40, p = 0.01), and NLR (r = –0.41, p = 0.01), particularly in PCOS patients where NLR had the strongest inverse correlation (r = –0.41, p < 0.01).
Conclusion: Vitamin D deficiency is significantly associated with elevated systemic inflammatory markers across T2DM, PCOS, and hypothyroidism. Routine screening and correction of vitamin D status may aid in mitigating inflammation in these endocrine disorders.
References
Rebelos E, Tentolouris N, Jude E. The Role of Vitamin D in Health and Disease: A Narrative Review on the Mechanisms Linking Vitamin D with Disease and the Effects of Supplementation. Drugs. 2023 ;83(8):665-685.
Wimalawansa SJ. Controlling Chronic Diseases and Acute Infections with Vitamin D Sufficiency. Nutrients. 2023 ;15(16):3623.
Ao T, Kikuta J, Ishii M. The Effects of Vitamin D on Immune System and Inflammatory Diseases. Biomolecules. 2021 ;11(11):1624.
Uccella S, Dottermusch M, Erickson L, Warmbier J, Montone K, Saeger W. Inflammatory and Infectious Disorders in Endocrine Pathology. Endocr Pathol. 2023 ;34(4):406-436.
Marques P, de Vries F, Dekkers OM, Korbonits M, Biermasz NR, Pereira AM. Serum Inflammation-based Scores in Endocrine Tumors. J Clin Endocrinol Metab. 2021 ;106(10):e3796-e3819.
Alexandraki KI, Kandaraki EA, Poulia KA, Piperi C, Papadimitriou E, Papaioannou TG. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome. touchREV Endocrinol. 2021;17(1):37-53.
L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti-Inflammatory. JBMR Plus. 2020 ;5(1):e10405.
Quesada-Gomez JM, Lopez-Miranda J, Entrenas-Castillo M, Casado-Díaz A, Nogues Y Solans X, Mansur JL, et al. Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol. Nutrients. 2022 ;14(13):2716.
DiNicolantonio JJ, O'Keefe JH. Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in covid-19 patients. Mo Med. 2021 ;118(1):68-73.
Kaviani M, Nikooyeh B, Etesam F, Behnagh SJ, Kangarani HM, Arefi M, et al. Effects of vitamin D supplementation on depression and some selected pro-inflammatory biomarkers: a double-blind randomized clinical trial. BMC Psychiatry. 2022 ;22(1):694.
Vernia F, Valvano M, Longo S, Cesaro N, Viscido A, Latella G. Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications. Nutrients. 2022 ;14(2):269.
Matikainen N, Pekkarinen T, Ryhänen EM, Schalin-Jäntti C. Physiology of Calcium Homeostasis: An Overview. Endocrinol Metab Clin North Am. 2021 ;50(4):575-590.
Aslam J, Sohailuddin M, Abbas SM, Shaikh MT, Saleem S, Mubeen A, Ahmad B, Haseeb M, Mzahri EU, Abbas SM, Shaikh MT. The Schematic Assessment of Vitamin D Deficiency in Relation to Autoimmune Disorders and Its Implications in Internal Medicine. Cureus. 2025 Apr 24;17(4).
Park CY, Shin S, Han SN. Multifaceted Roles of Vitamin D for Diabetes: From Immunomodulatory Functions to Metabolic Regulations. Nutrients. 2024 ;16(18):3185.
Rhee JJ, Han J, Montez‐Rath ME, Chertow GM. Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, Obesity and Metabolism. 2024 Apr;26(4):1273-81.
Shan R, Zhang Q, Ding Y, Zhang L, Dong Y, Gao W. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights. Open Life Sci. 2024 ;19(1):20220787.
Gu JC, Wu YG, Huang WG, Fan XJ, Chen XH, Zhou B, et al. Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes. J Clin Lab Anal. 2022 ;36(5):e24430.
Ahmed S, Ahmed M, Abbas F, Wahab A, Pathan S, Singla B, Ismail S, Khaliq M, Shah MH, SINGLA B. Evaluating Hepatokines in the Progression of Non-alcoholic Fatty Acid Liver Disease by Decoding Liver-Derived Molecular Pathologies. Cureus. 2025 May 16;17(5).
Litwiniuk A, Bik W, Kalisz M, Baranowska-Bik A. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease. Int J Mol Sci. 2021 ;22(11):5603.
Zhao JF, Li BX, Zhang Q. Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study. Ann Palliat Med. 2021 ;10(1):169-183.
Appunni S, Rubens M, Ramamoorthy V, Saxena A, Tonse R, Veledar E, et al. Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007-2012. BMC Endocr Disord. 2021 ;21(1):224.
Tellechea ML. Meta-analytic evidence for increased low-grade systemic inflammation and oxidative stress in hypothyroid patients. Can levothyroxine replacement therapy mitigate the burden? Endocrine. 2021 ;72(1):62-71.
Szymczak-Pajor I, Miazek K, Selmi A, Balcerczyk A, Śliwińska A. The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders? Int J Mol Sci. 2022 ;23(2):956.
Fletcher J, Bishop EL, Harrison SR, Swift A, Cooper SC, Dimeloe SK, et al. Autoimmune disease and interconnections with vitamin D. Endocr Connect. 2022 ;11(3):e210554.
Galușca D, Popoviciu MS, Babeș EE, Vidican M, Zaha AA, Babeș VV, et al. Vitamin D Implications and Effect of Supplementation in Endocrine Disorders: Autoimmune Thyroid Disorders (Hashimoto's Disease and Grave's Disease), Diabetes Mellitus and Obesity. Medicina (Kaunas). 2022 ;58(2):194.
Dey SK, Kumar S, Rani D, Maurya SK, Banerjee P, Verma M, et al. Implications of vitamin D deficiency in systemic inflammation and cardiovascular health. Crit Rev Food Sci Nutr. 2024;64(28):10438-10455.
Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024 ;109(8):1907-1947.
Rasouli N, Brodsky IG, Chatterjee R, Kim SH, Pratley RE, Staten MA, et al. Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes. J oClin Endocrinol Metab. 2022 ;107(1):230-240.
Anwar B, Nangdev P, Yousaf Q, Aslam U, Mastoor M, Khaliq H. Crosslinking neuropharmacology and pathology: Luteolin based therapy in In-Vivo experiments. Rawal Medical Journal. 2024 Nov 10;49(4):950-. (No doi)
Khaliq H. Eugenol’s anti-proliferative therapeutic potential for leukemia pathology; Insights from HL-60 cells. Rawal Medical Journal. 2024 Oct;49(4):803. (No doi)
Afridi A, Khan MA, Khan S, Khaliq H, Azhar T, Khan E. Pathological Insights to Polycystic Ovary Syndrome: Crosslinking Decreased Brain-Derived Neurotrophic Factor (BDNF) Levels with a multi-system disorder. Rawal Medical Journal. 2025 Mar 4;50(1):125.
Afridi A, Wadood M, Shaikh AR, Jehangir AM, Minhas M, Khaliq H. Diagnostics pathology insights to pro-apoptotic potential of eugenol against human cervical cancer cell line. Rawal Medical Journal. 2025 May 12;50(2):374.
Bibi F, Dilshad M, Tanvir S, Rehmatullah A, Arjumand S, Khaliq H. Evaluating Capsaicin's anti-cancer potential: A diagnostic perspective in human cervical cancer cells. Rawal Medical Journal. 2025 May 12;50(2):370.
Khaliq HM, Aziz O, Wadhwa M, Imran S. In vitro insights: Investigating Pro-apoptotic potential of capsaicin against HL-60, Human Leukemia cell line. Rawal Medical Journal. 2024 Aug 8;49(3):661.
Nangdev P, Bughio R, Ghani A, Parveen K, Wadhwa M, Khaliq HM. Investigating Hesperidin as a potential neuroprotective agent for Autism-induced Rats Models. Rawal Medical Journal. 2024 Jul;49(3):665.
Rafiq T, Fatima H, Niaz M, Khan SA, Minhas M, Khaliq H. Comparative accuracy of CT and MRI in diagnosis of pituitary microadenoma. Rawal Medical Journal. 2025 May 12;50(2):329.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Haseeb Khaliq (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
